PsyBio Therapeutics (TSE:PSYB.H)
TSXV:PSYB.H
Canadian Market
Holding TSE:PSYB.H?
Track your performance easily

PsyBio Therapeutics (PSYB.H) Financial Statements

11 Followers

PsyBio Therapeutics Financial Overview

PsyBio Therapeutics's market cap is currently ―. The company's EPS TTM is C$-0.041; its P/E ratio is -0.24; PsyBio Therapeutics is scheduled to report earnings on August 26, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -181.99K$ -811.49K$ -941.64K$ -921.90K$ -1.43M
EBITDA$ -181.99K$ -773.47K--$ -1.39M
Net Income Common Stockholders$ -181.99K$ -811.49K$ -941.64K$ -921.90K$ -1.44M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 12.37K$ 69.02K$ 848.00$ 180.64K$ 911.83K
Total Assets$ 283.14K$ 299.83K$ 390.37K$ 506.70K$ 1.29M
Total Debt$ 96.14K$ 96.14K$ 135.49K$ 172.15K$ 207.81K
Net Debt$ 83.77K$ 27.12K$ 134.64K$ -8.49K$ -704.01K
Total Liabilities$ 1.97M$ 1.96M$ 1.98M$ 1.31M$ 1.26M
Stockholders Equity$ -1.69M$ -1.66M$ -1.59M$ -807.87K$ 29.55K
Cash Flow-
Free Cash Flow$ -361.72K$ -355.49K$ -165.98K$ -3.27M$ -1.30M
Operating Cash Flow$ -361.72K$ -355.49K$ -165.98K$ -3.27M$ -1.30M
Investing Cash Flow$ 622.00--$ 3.52M$ 1.38M
Financing Cash Flow$ 558.71K$ 290.83K$ 142.71K$ -197.69K$ -124.28K
Currency in USD

PsyBio Therapeutics Earnings and Revenue History

PsyBio Therapeutics Debt to Assets

PsyBio Therapeutics Cash Flow

PsyBio Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis